{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:42:56Z","timestamp":1772268176614,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Abnormal activation of the coagulation system has been reported in patients with malignancies, but its prognostic significance in biliary tract cancer (BTC) remains unclear. This study aims to analyze and compare the prognostic value of coagulation indices in patients with BTC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The medical records of 450 patients with BTC who underwent surgical resection at our hospital between 2003 and 2017 were retrospectively analyzed. Time-dependent receiver operating characteristic curves were plotted to compare the predictive accuracy of coagulation indices. A predictive nomogram for overall survival (OS) was established based on the Cox regression analysis and validated in both the training and validation cohorts. A novel stratification model was created according to the total points of the nomogram.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fibrinogen and international normalized ratio (INR) had the best predictive accuracy among the coagulation indices considered and were also the independent prognostic factors for OS. The nomogram and the novel stratification model had satisfactory performance and outperformed TNM staging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study demonstrated that coagulation indices are valuable in predicting OS in BTC, with fibrinogen and INR having the best predictive ability. The nomogram and the novel stratification model could be applied to predict survival for patients with BTC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08684-w","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T17:03:54Z","timestamp":1629911034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Xindi","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinting","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouxian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-3559","authenticated-orcid":false,"given":"Huayu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0449-4223","authenticated-orcid":false,"given":"Yilei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9357-3259","authenticated-orcid":false,"given":"Shunda","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"issue":"36","key":"8684_CR1","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1200\/EDBK_160831","volume":"36","author":"JA Bridgewater","year":"2016","unstructured":"Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling. Am Soc Clin Oncol Educ Book. 2016;36(36):e194\u2013203. https:\/\/doi.org\/10.1200\/EDBK_160831.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"8684_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.21037\/hbsn.2019.09.06","volume":"9","author":"P Gavriilidis","year":"2020","unstructured":"Gavriilidis P, Askari A, Roberts KJ, Sutcliffe RP. Appraisal of the current guidelines for management of cholangiocarcinoma\u2014using the appraisal of guidelines research and evaluation II (AGREE II) instrument. Hepatobiliary Surg Nutr. 2020;9(2):126\u201335. https:\/\/doi.org\/10.21037\/hbsn.2019.09.06.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"2","key":"8684_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21037\/hbsn.2017.12.14","volume":"7","author":"A Gorgen","year":"2018","unstructured":"Gorgen A, Goldaracena N, Zhang W, Sapisochin G. Intrahepatic cholangiocarcinoma, are we making progress? Hepatobiliary Surg Nutr. 2018;7(2):127\u20139. https:\/\/doi.org\/10.21037\/hbsn.2017.12.14.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"5","key":"8684_CR4","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/cancers12051237","volume":"12","author":"E Oneda","year":"2020","unstructured":"Oneda E, Abu Hilal M, Zaniboni A. Biliary tract Cancer: current medical treatment strategies. Cancers (Basel). 2020;12(5):1237\u201350. https:\/\/doi.org\/10.3390\/cancers12051237.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"8684_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.21037\/hbsn.2018.11.21","volume":"8","author":"A Doussot","year":"2019","unstructured":"Doussot A, Jarnagin WR, Azoulay D, Heyd B. Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma\u2014still a long way to go. HepatoBiliary Surg Nutr. 2019;8(2):161\u20133. https:\/\/doi.org\/10.21037\/hbsn.2018.11.21.","journal-title":"HepatoBiliary Surg Nutr"},{"issue":"18","key":"8684_CR6","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","volume":"341","author":"PC de Groen","year":"1999","unstructured":"de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341(18):1368\u201378. https:\/\/doi.org\/10.1056\/NEJM199910283411807.","journal-title":"N Engl J Med"},{"issue":"29","key":"8684_CR7","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1200\/JCO.2009.22.3032","volume":"27","author":"GH Lyman","year":"2009","unstructured":"Lyman GH, Khorana AA. Cancer, clots and consensus: new understanding of an old problem. J Clin Oncol. 2009;27(29):4821\u20136. https:\/\/doi.org\/10.1200\/JCO.2009.22.3032.","journal-title":"J Clin Oncol"},{"issue":"3","key":"8684_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.thromres.2011.12.022","volume":"129","author":"MB Donati","year":"2012","unstructured":"Donati MB, Lorenzet R. Thrombosis and cancer: 40 years of research. Thromb Res. 2012;129(3):348\u201352. https:\/\/doi.org\/10.1016\/j.thromres.2011.12.022.","journal-title":"Thromb Res"},{"issue":"2","key":"8684_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jth.12075","volume":"11","author":"A Falanga","year":"2013","unstructured":"Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2013;11(2):223\u201333. https:\/\/doi.org\/10.1111\/jth.12075.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"8684_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.beha.2008.12.009","volume":"22","author":"A Falanga","year":"2009","unstructured":"Falanga A, Panova-Noeva M, Russo L. Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol. 2009;22(1):49\u201360. https:\/\/doi.org\/10.1016\/j.beha.2008.12.009.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"8684_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MOH.0000000000000072","volume":"21","author":"A Falanga","year":"2014","unstructured":"Falanga A, Russo L, Milesi V. The coagulopathy of cancer. Curr Opin Hematol. 2014;21(5):423\u20139. https:\/\/doi.org\/10.1097\/MOH.0000000000000072.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"8684_CR12","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.suronc.2009.03.008","volume":"19","author":"S Kvolik","year":"2010","unstructured":"Kvolik S, Jukic M, Matijevic M, Marjanovic K, Glavas-Obrovac L. An overview of coagulation disorders in cancer patients. Surg Oncol. 2010;19(1):e33\u201346. https:\/\/doi.org\/10.1016\/j.suronc.2009.03.008.","journal-title":"Surg Oncol"},{"issue":"5","key":"8684_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/CMR.0b013e328357be7c","volume":"22","author":"F Tas","year":"2012","unstructured":"Tas F, Ciftci R, Kilic L, Bilgin E, Keskin S, Sen F, et al. Clinical and prognostic significance of coagulation assays in melanoma. Melanoma Res. 2012;22(5):368\u201375. https:\/\/doi.org\/10.1097\/CMR.0b013e328357be7c.","journal-title":"Melanoma Res"},{"issue":"6","key":"8684_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/01.coc.0000436088.69084.22","volume":"38","author":"W Sun","year":"2015","unstructured":"Sun W, Ren H, Gao CT, Ma WD, Luo L, Liu Y, et al. Clinical and prognostic significance of coagulation assays in pancreatic cancer patients with absence of venous thromboembolism. Am J Clin Oncol. 2015;38(6):550\u20136. https:\/\/doi.org\/10.1097\/01.coc.0000436088.69084.22.","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"8684_CR15","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.3892\/ol.2017.6058","volume":"13","author":"S Lee","year":"2017","unstructured":"Lee S, Huh SJ, Oh SY, Koh MS, Kim SH, Lee JH, et al. Clinical significance of coagulation factors in operable colorectal cancer. Oncol Lett. 2017;13(6):4669\u201374. https:\/\/doi.org\/10.3892\/ol.2017.6058.","journal-title":"Oncol Lett"},{"issue":"2","key":"8684_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.pan.2018.12.010","volume":"19","author":"K Zhang","year":"2019","unstructured":"Zhang K, Gao HF, Mo M, Wu CJ, Hua YQ, Chen Z, et al. A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer. Pancreatology. 2019;19(2):346\u201351. https:\/\/doi.org\/10.1016\/j.pan.2018.12.010.","journal-title":"Pancreatology"},{"key":"8684_CR17","doi-asserted-by":"publisher","first-page":"9947","DOI":"10.2147\/OTT.S222813","volume":"12","author":"Q Li","year":"2019","unstructured":"Li Q, Cong R, Kong F, Ma J, Wu Q, Ma X. Fibrinogen is a coagulation marker associated with the prognosis of endometrial cancer. Onco Targets Ther. 2019;12:9947\u201356. https:\/\/doi.org\/10.2147\/OTT.S222813.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"8684_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.rmed.2012.11.007","volume":"107","author":"F Tas","year":"2013","unstructured":"Tas F, Kilic L, Serilmez M, Keskin S, Sen F, Duranyildiz D. Clinical and prognostic significance of coagulation assays in lung cancer. Respir Med. 2013;107(3):451\u20137. https:\/\/doi.org\/10.1016\/j.rmed.2012.11.007.","journal-title":"Respir Med"},{"issue":"1","key":"8684_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1749-6632.2001.tb03525.x","volume":"936","author":"PJ Simpson-Haidaris","year":"2001","unstructured":"Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. Ann N Y Acad Sci. 2001;936(1):406\u201325.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8684_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1172\/JCI111661","volume":"75","author":"E Dejana","year":"1985","unstructured":"Dejana E, Languino LR, Polentarutti N, Balconi G, Ryckewaert JJ, Larrieu MJ, et al. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest. 1985;75(1):11\u20138. https:\/\/doi.org\/10.1172\/JCI111661.","journal-title":"J Clin Invest"},{"issue":"12","key":"8684_CR21","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1182\/blood.V96.12.3772","volume":"96","author":"A Sahni","year":"2000","unstructured":"Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood. 2000;96(12):3772\u20138. https:\/\/doi.org\/10.1182\/blood.V96.12.3772.","journal-title":"Blood"},{"issue":"1","key":"8684_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1538-7836.2007.02808.x","volume":"6","author":"A Sahni","year":"2008","unstructured":"Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost. 2008;6(1):176\u201383. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02808.x.","journal-title":"J Thromb Haemost"},{"issue":"10","key":"8684_CR23","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1182\/blood.V96.10.3302","volume":"96","author":"JS Palumbo","year":"2000","unstructured":"Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000;96(10):3302\u20139. https:\/\/doi.org\/10.1182\/blood.V96.10.3302.","journal-title":"Blood"},{"issue":"1","key":"8684_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/1471-2407-14-566","volume":"14","author":"YJ Shu","year":"2014","unstructured":"Shu YJ, Weng H, Bao RF, Wu XS, Ding Q, Cao Y, et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer. 2014;14(1):566. https:\/\/doi.org\/10.1186\/1471-2407-14-566.","journal-title":"BMC Cancer"},{"issue":"1","key":"8684_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/IGC.0000000000000303","volume":"25","author":"YN Man","year":"2015","unstructured":"Man YN, Wang YN, Hao J, Liu X, Liu C, Zhu C, et al. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism. Int J Gynecol Cancer. 2015;25(1):24\u201332. https:\/\/doi.org\/10.1097\/IGC.0000000000000303.","journal-title":"Int J Gynecol Cancer"},{"key":"8684_CR26","doi-asserted-by":"publisher","unstructured":"Qi Q, Geng Y, Sun M, Chen H, Wang P, Chen Z: Hyperfibrinogen is associated with the systemic inflammatory response and predicts poor prognosis in advanced pancreatic cancer. Pancreas. 2015;44(6):977-82. https:\/\/doi.org\/10.1097\/MPA.0000000000000353.","DOI":"10.1097\/MPA.0000000000000353"},{"issue":"3","key":"8684_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.suronc.2017.07.001","volume":"26","author":"JS Tsang","year":"2017","unstructured":"Tsang JS, Chok KSH, Lo CM. Role of hepatic trisectionectomy in advanced hepatocellular carcinoma. Surg Oncol. 2017;26(3):310\u20137. https:\/\/doi.org\/10.1016\/j.suronc.2017.07.001.","journal-title":"Surg Oncol"},{"issue":"12","key":"8684_CR28","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1111\/liv.13517","volume":"37","author":"N Schweitzer","year":"2017","unstructured":"Schweitzer N, Fischer M, Kirstein MM, Berhane S, Kottas M, Sinn M, et al. Risk estimation for biliary tract cancer: development and validation of a prognostic score. Liver Int. 2017;37(12):1852\u201360. https:\/\/doi.org\/10.1111\/liv.13517.","journal-title":"Liver Int"},{"issue":"4","key":"8684_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5582\/bst.2017.01080","volume":"11","author":"H Wang","year":"2017","unstructured":"Wang H, Liu W, Tian M, Tang Z, Jiang X, Zhou P, et al. Coagulopathy associated with poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection. Biosci Trends. 2017;11(4):469\u201374. https:\/\/doi.org\/10.5582\/bst.2017.01080.","journal-title":"Biosci Trends"},{"issue":"2","key":"8684_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.6004\/jnccn.2019.7357","volume":"18","author":"S Yadav","year":"2020","unstructured":"Yadav S, Tella SH, Kommalapati A, Mara K, Prasai K, Mady MH, et al. A novel clinically based staging system for gallbladder Cancer. J Natl Compr Canc Netw. 2020;18(2):151\u20139. https:\/\/doi.org\/10.6004\/jnccn.2019.7357.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08684-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08684-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08684-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T17:03:57Z","timestamp":1629911037000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08684-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8684"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08684-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"22 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical standards of the Declaration of Helsinki and has been approved by the Institutional Review Board of Peking Union Medical College Hospital (S-K1110). Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors disclose no conflicts.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"953"}}